BriaCell Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BCTX and other ETFs, options, and stocks.About BCTX
BriaCell Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the development of novel immunotherapies to transform cancer care. It currently advancing its Bria-IMT™ targeted immunotherapy in combination with an immune check point inhibitor in a pivotal 1 Phase 3 study in metastatic breast cancer.
CEOWilliam V. Williams
CEOWilliam V. Williams
Employees17
Employees17
HeadquartersWest Vancouver, British Columbia
HeadquartersWest Vancouver, British Columbia
Founded2006
Founded2006
Employees17
Employees17
BCTX Key Statistics
Market cap25.53M
Market cap25.53M
Price-Earnings ratio-0.18
Price-Earnings ratio-0.18
Dividend yield—
Dividend yield—
Average volume122.57K
Average volume122.57K
High today$13.90
High today$13.90
Low today$13.27
Low today$13.27
Open price$13.78
Open price$13.78
Volume52.51K
Volume52.51K
52 Week high$190.50
52 Week high$190.50
52 Week low$6.00
52 Week low$6.00
BCTX News
Nasdaq 6d
BriaCell Rises On Phase 3 Expansion And MSK Collaboration(RTTNews) - BriaCell Therapeutics Corp. (BCTX) rose 4.16% to trade at $12.77, up $0.51, following news of a collaboration with Memorial Sloan Kettering Cancer C...
People also own
Based on the portfolios of people who own BCTX. This list is generated using Robinhood data, and it’s not a recommendation.